Collaboration combines Saudi Arabia's national health data capabilities with Flagship's life sciences and AI-enabled innovation expertise to accelerate precision medicine, scientific discovery, and ...

Summary: For the average viewer, watching a cinematic film feels entirely effortless. We simultaneously digest spoken dialogue, track microscopic facial expressions, notice subtle background musical ...

For years, healthcare organizations have operated on the assumption that if you fill out the right paperwork, be it a SOC 2 report, a HITRUST (Health Information Trust Alliance) certification, or a ...

The American Hospital Association is positioning technology — from EHRs to predictive analytics — as a central lever in hospitals’ push to lower healthcare costs. AHA President and CEO Rick Pollack ...

Recent developments suggest that major health care and life sciences organizations are expanding their use of AI beyond trial initiatives and targeted applications, while federal and state ...

Editor’s note: This story has been updated following the passage and release of the final map by Tennessee lawmakers Tennessee Republicans are moving ahead with a new congressional map for the 2026 ...

Recent reporting has drawn attention to an alarming new trend: video content aimed at young kids that is generated by artificial intelligence and is popping up on YouTube at a shocking rate. These ...

Microsoft has rolled out Visual Studio Code 1.118, just days after releasing version 1.117, continuing its rapid update cycle with a strong focus on AI-powered development and enterprise controls. One ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. As if ...

VS Code 1.117 adds BYOK support for Copilot Business and Enterprise users. Admins can control whether managed users can access BYOK capabilities. The release also updates chat rendering, agent ...

Eli Lilly's LLY.N GLP-1 drug tirzepatide yields greater weight loss on average than Novo Nordisk's NOVOb.CO semaglutide, but at a greater expense to muscles and connective tissues, according to a ...